[North Land Pharmaceutical Industry: repaglinide tablets pass generic Drug consistency Evaluation] May 31, Beilu Pharmaceutical announced that recently, the company received a "Drug Supplementary Application approval notice" issued by the State Drug Administration for repaglinide tablets. Repaglinide tablets passed the consistency evaluation of generic drug quality and efficacy. Repaglinide tablets are non-sulfonylurea insulin secreting agents and are therapeutic drugs for patients with type 2 diabetes.